Positive results from the Phase II study of uTRACE in brain

/PRNewswire/ -- Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS) announces today that the previously announced results from the...

Related Keywords

Copenhagen , Køavn , Denmark , Prague , Praha , Hlavníesto , Czech Republic , Aleena Azam , Ulrich Krasilnikoff , World Molecular Imaging Congress , University Of Copenhagen , Primary Gliomas , Prognostic Value , Targeted Radionuclide , Molecular Imaging , Springer Publisher , Positron Emissions Tomography , Radionuclide Therapy , Curasight ,